This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Molina Healthcare's (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 earnings beat on the back of an effective performance management and a margin recovery plan.
Molina (MOH) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 64.85% and -0.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Q3 Earnings to Watch on Oct 31: ANTM, MOH, ESRX
by Zacks Equity Research
Healthcare stocks should gain from increase in revenues, higher premiums and enrollment partly offset by increase in expenses.
Zacks.com highlights: Tilly's, Crocs, Cadence Design Systems and Molina Healthcare
by Zacks Equity Research
Zacks.com highlights: Tilly's, Crocs, Cadence Design Systems and Molina Healthcare
What's in the Offing for Aetna (AET) This Earnings Season?
by Zacks Equity Research
Aetna's (AET) third-quarter earnings to gain from higher revenues, partly offset by increase in expenses.
Can Healthy Top-Line Growth Aid Ribbon's (RBBN) Q3 Earnings?
by Zacks Equity Research
Ribbon (RBBN) is likely to report higher year-over-year revenues in the third quarter of 2018 owing to healthy organic and inorganic growth initiatives.
Molina Healthcare's (MOH) Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Molina Healthcare (MOH) is likely to perform well in the third quarter on the back of a solid Medicaid business and its operational excellence.
4 Impressive Liquid Stocks for Maximum Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that can help investors build a winning portfolio.
Will Expenses Hurt WellCare Health's (WCG) Q3 Earnings?
by Zacks Equity Research
WellCare Health's (WCG) Q3 bottom line might suffer due to escalating expenses.
Should iShares Morningstar Small-Cap ETF (JKJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKJ
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina, WellCare, Humana and UnitedHealth
Universal Health Services (UHS) Q3 Earnings: A Beat in the Cards?
by Zacks Equity Research
United Health's (UHS) third quarter is likely to gain from solid segmental performances and higher number of admissions.
Molina (MOH) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Obamacare Set to Gain From Mid-Term Polls: 4 HMO Picks
by Swarup Gupta
HMOs, which have expanded their market share in the post-Obamacare era, are expected to gain from this trend.
Centene's (CNC) Earnings and Revenues Top Estimates in Q3
by Zacks Equity Research
Execution of growth strategy as well as the company's solid operating metrics leads Centene (CNC) to an earnings beat in Q3.
Molina Healthcare (MOH) Divests Arm to Streamline Business
by Zacks Equity Research
Molina Healthcare (MOH) sells its subsidiary Pathways Health and Community Support, LLC to focus on core business and continue with its plan for margin recovery sustainability.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
New Strong Buy Stocks for October 23rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday
What's in Store for Centene (CNC) This Earnings Season?
by Zacks Equity Research
Centene's (CNC) third quarter should exhibit strong performances by its Government-backed and Medicaid businesses.
UnitedHealth's (UNH) Q3 Earnings Beat, 2018 Guidance Raised
by Zacks Equity Research
UnitedHealth's (UNH) Q3 results gained from higher revenues from both its segments and increase in membership.
Will Optum Aid UnitedHealth Group's (UNH) Q3 Earnings?
by Zacks Equity Research
Revenue and earnings gains across all the Optum's subsegments should aid UnitedHealth's Q3 earnings.
Will UnitedHealth's (UNH) Revenue Growth Aid Q3 Earnings?
by Zacks Equity Research
Revenue growth at the company's Optum and United Healthcare segments should drive earnings in Q3.
Why the Earnings Surprise Streak Could Continue for Molina (MOH)
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Molina Healthcare Sells MMS Unit to Streamline Business
by Zacks Equity Research
Molina Healthcare (MOH) sells its Medicaid Solutions unit to focus on core operations.